[Journal logo]

Volume 65 
Part 3 
Page o518  
March 2009  

Received 27 December 2008
Accepted 7 February 2009
Online 13 February 2009

Key indicators
Single-crystal X-ray study
T = 296 K
Mean [sigma](C-C) = 0.003 Å
R = 0.040
wR = 0.104
Data-to-parameter ratio = 11.7
Details
Open access

4-(4-Carboxybenzyl)-1-methylpiperazin-1-ium picrate

aKey Laboratory of Science and Technology of Eco-Textiles, Ministry of Education, College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai 201620, People's Republic of China,bDepartment of Studies in Chemistry, University of Mysore, Manasagangotri, Mysore 570 006, India,cDepartment of Studies in Chemistry, Mangalore University, Mangalagangotri 574 199, India, and dRL Fine Chem, Bangalore 560 064, India
Correspondence e-mail: hongqili@dhu.edu.cn

The title compound, C13H19N2O2+·C6H2N3O7-, is a salt obtained by cocrystallization of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid and picric acid. The cations adopt an `L-shaped' conformation and are linked into chains along [010] by O-H...N hydrogen bonds. The NH group of each piperazinium ring forms a hydrogen bond to the phenolate O atom of a picrate anion, and the picrate anions form face-to-face contacts with an interplanar separation of 3.023 (1) Å.

Related literature

For general background, see: Druker et al. (2001[Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R. & Talpaz, M. N. (2001). N. Engl. J. Med. 344, 1038-1042.]). For related structures, see: Swamy et al. (2007[Swamy, M. T., Ashok, M. A., Yathirajan, H. S., Narayana, B. & Bolte, M. (2007). Acta Cryst. E63, o4919.]); Bindya et al. (2007[Bindya, S., Wong, W.-T., Ashok, M. A., Yathirajan, H. S. & Rathore, R. S. (2007). Acta Cryst. C63, o546-o548.]); Sarojini et al. (2007[Sarojini, B. K., Yathirajan, H. S., Mustafa, K., Sarfraz, H. & Bolte, M. (2007). Acta Cryst. E63, o4477.]); Wang & Jia (2008[Wang, Z.-L. & Jia, L.-H. (2008). Acta Cryst. E64, o665-o666.]).

[Scheme 1]

Experimental

Crystal data
  • C13H19N2O2+·C6H2N3O7-

  • Mr = 463.41

  • Triclinic, [P \overline 1]

  • a = 7.3020 (12) Å

  • b = 9.5993 (16) Å

  • c = 15.131 (3) Å

  • [alpha] = 86.448 (2)°

  • [beta] = 79.145 (2)°

  • [gamma] = 79.950 (2)°

  • V = 1025.2 (3) Å3

  • Z = 2

  • Mo K[alpha] radiation

  • [mu] = 0.12 mm-1

  • T = 296 K

  • 0.30 × 0.20 × 0.20 mm

Data collection
  • Bruker SMART CCD diffractometer

  • Absorption correction: multi-scan (SADABS; Sheldrick, 2004[Sheldrick, G. M. (2004). SADABS. University of Göttingen, Germany.]) Tmin = 0.965, Tmax = 0.976

  • 5373 measured reflections

  • 3565 independent reflections

  • 2745 reflections with I > 2[sigma](I)

  • Rint = 0.016

Refinement
  • R[F2 > 2[sigma](F2)] = 0.040

  • wR(F2) = 0.104

  • S = 1.06

  • 3565 reflections

  • 305 parameters

  • H atoms treated by a mixture of independent and constrained refinement

  • [Delta][rho]max = 0.18 e Å-3

  • [Delta][rho]min = -0.17 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
O8-H8...N4i 0.82 1.79 2.6006 (19) 172
N5-H5A...O1ii 0.89 (2) 1.89 (2) 2.734 (2) 156.9 (18)
Symmetry codes: (i) x, y+1, z; (ii) -x+1, -y+2, -z+1.

Data collection: SMART (Bruker, 2001[Bruker (2001). SMART and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT (Bruker, 2001[Bruker (2001). SMART and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: SHELXTL (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); software used to prepare material for publication: SHELXTL.


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: BI2341 ).


Acknowledgements

QNMHA thanks R. L. Fine Chem, Bangalore, for a gift sample of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid. HSY thanks the University of Mysore for research facilities.

References

Bindya, S., Wong, W.-T., Ashok, M. A., Yathirajan, H. S. & Rathore, R. S. (2007). Acta Cryst. C63, o546-o548.  [CSD] [CrossRef] [ChemPort] [details]
Bruker (2001). SMART and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R. & Talpaz, M. N. (2001). N. Engl. J. Med. 344, 1038-1042.  [CrossRef] [PubMed] [ChemPort]
Sarojini, B. K., Yathirajan, H. S., Mustafa, K., Sarfraz, H. & Bolte, M. (2007). Acta Cryst. E63, o4477.  [CSD] [CrossRef] [details]
Sheldrick, G. M. (2004). SADABS. University of Göttingen, Germany.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Swamy, M. T., Ashok, M. A., Yathirajan, H. S., Narayana, B. & Bolte, M. (2007). Acta Cryst. E63, o4919.  [CSD] [CrossRef] [details]
Wang, Z.-L. & Jia, L.-H. (2008). Acta Cryst. E64, o665-o666.  [CSD] [CrossRef] [details]


Acta Cryst (2009). E65, o518  [ doi:10.1107/S1600536809004474 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.